We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+11.09%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
–
AUM
$11.4B
AUM Growth
+$1.29B
Cap. Flow
+$528M
Cap. Flow %
4.63%
Top 10 Hldgs %
25.25%
Holding
2,093
New
704
Increased
330
Reduced
366
Closed
687

Top Buys

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$75M
2
CVX icon
Chevron
CVX
+$59.9M
3
GEHC icon
GE HealthCare
GEHC
+$57.5M
4
APP icon
Applovin
APP
+$54.7M
5
OKLO
Oklo
OKLO
+$52.8M

Top Sells

Rank Stock Value
1
XEL icon
Xcel Energy
XEL
+$137M
2
META icon
Meta Platforms (Facebook)
META
+$61.8M
3
BDX icon
Becton Dickinson
BDX
+$59.9M
4
CRWV
CoreWeave
CRWV
+$57.1M
5
AAPL icon
Apple
AAPL
+$50.2M

Sector Composition

Rank Sector Weight
1 Healthcare 11.73%
2 Financials 9.81%
3 Utilities 8.63%
4 Technology 7.6%
5 Industrials 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLMT icon
1526
Calumet Specialty Products
CLMT
$4.31B
– –
-59,941
Closed -$760K
CLPR
1527
Clipper Realty
CLPR
$53M
– –
-49,583
Closed -$190K
CLOV icon
1528
Clover Health Investments
CLOV
$2.2B
– –
-58,798
Closed -$211K
CLPT icon
1529
ClearPoint Neuro
CLPT
$469M
– –
-45,775
Closed -$544K
CLS icon
1530
Celestica
CLS
$37.4B
– –
-81,293
Closed -$6.41M
CLW icon
1531
Clearwater Paper
CLW
$351M
– –
-67,136
Closed -$1.7M
CLX icon
1532
Clorox
CLX
$12.9B
– –
-75,132
Closed -$11.1M
CMP icon
1533
Compass Minerals
CMP
$1.09B
– –
-55,966
Closed -$520K
CNO icon
1534
CNO Financial Group
CNO
$4.95B
– –
-38,509
Closed -$1.6M
COHR icon
1535
Coherent
COHR
$56.7B
– –
-76,293
Closed -$4.95M
COLD icon
1536
Americold
COLD
$4.35B
– –
-1,138,644
Closed -$24.4M
COLL icon
1537
Collegium Pharmaceutical
COLL
$840M
– –
-196,491
Closed -$5.87M
COLM icon
1538
Columbia Sportswear
COLM
$3.09B
– –
-53,850
Closed -$4.08M
COR icon
1539
Cencora
COR
$60.7B
– –
-4,988
Closed -$1.39M
CORZ icon
1540
PUT
Core Scientific
CORZ
$5.72B
– –
-159,200
Closed -$1.15M
CPB icon
1541
Campbell Soup
CPB
$7.14B
– –
-5,173
Closed -$207K
CPF icon
1542
Central Pacific Financial
CPF
$964M
– –
-79,017
Closed -$2.14M
CPNG icon
1543
Coupang
CPNG
$29.6B
– –
-109,758
Closed -$2.41M
CRDO icon
1544
Credo Technology Group
CRDO
$43B
– –
-137,127
Closed -$5.51M
CRGY icon
1545
Crescent Energy
CRGY
$4.65B
– –
-560,475
Closed -$6.3M
CRI icon
1546
Carter's
CRI
$1.31B
– –
-201,251
Closed -$8.23M
CRSP icon
1547
CRISPR Therapeutics
CRSP
$5.75B
– –
-91,303
Closed -$3.11M
CRVS icon
1548
Corvus Pharmaceuticals
CRVS
$1.22B
– –
-199,358
Closed -$634K
CSCO icon
1549
Cisco
CSCO
$438B
– –
-4,924
Closed -$304K
CSTL icon
1550
Castle Biosciences
CSTL
$1.04B
– –
-77,563
Closed -$1.55M
60 61
62
63 64

Similar funds

FGP
Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Michael Gelband's Q2 2025 Portfolio in Review

As of Q2 2025, Michael Gelband held 2,093 positions worth $11.4B, up 13% from $10.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Michael Gelband deployed $528M of net new capital in Q2 2025, opening 704 new positions and adding to 330 existing holdings. Its largest new stake was Chevron: 424,949 shares worth $60.8M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Financials and Utilities.

On the sell side, the largest reduction was Xcel Energy, an estimated $137M trimmed.

  • Michael Gelband's largest Q2 2025 buy was Chevron: 424,949 shares worth $60.8M.
  • Michael Gelband added most to Paramount Global Class B in Q2 2025, an estimated $75M increase.
  • Michael Gelband's biggest Q2 2025 reduction was Xcel Energy, cutting an estimated $137M.
  • Michael Gelband fully exited Meta Platforms (Facebook) in Q2 2025, selling an estimated $61.8M.
  • Michael Gelband's ten largest holdings make up 25% of its $11.4B portfolio in Q2 2025.
  • Michael Gelband opened 704 new positions and closed 687 in Q2 2025.
  • Michael Gelband's portfolio value rose 13% quarter-over-quarter to $11.4B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.